Clinical Trials Sponsored by Angela Contri

Total 18634 results

Angela Contri

Completed

Translation and Psychometric Validation of an Italian Version of the Dance Functional Outcome Survey DFOS-IT (DFOS-IT)

Low Back Pain | Musculoskeletal Pain | Injuries | Lower Limb Injury | Limitation, Mobility | Health Impairment

Italy
Children's Hospital Los Angeles
Gabrielle's Angel Foundation

Completed

Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)

B Precursor Type Acute Leukemia

United States
Associazione Salentina Angela Serra

Unknown

Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients

Chemotherapy Induced Nausea and Vomiting

Italy
University Hospital, Angers
Ligue contre le cancer, France

Recruiting

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI) (CALRSUIVI)

Essential Thrombocythemia | Myeloproliferative Neoplasm | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

France
Centro Universitario contra el Cáncer

Completed

Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

Metastatic Breast Cancer

Mexico
University Hospital, Angers
Centre Hospitalier de Cholet

Not yet recruiting

Study of the Efficience of Chewing-gum to Reduce the Duration of Postoperative Ileus (CHEWIP)

Postoperative Ileus

France
Centre Hospitalier le Mans
University Hospital, Angers

Completed

Prospective Evaluation of Topical Analgesia for Laceration Repair in the Emergency Department

Pain, Acute | Laceration

France
Adela Drozdova

Not yet recruiting

Use of VR in Patients' Education Prior to Implantation of PPM

Pacemaker DDD
Adela Drozdova

Not yet recruiting

VR Education in Patients Undergoing Coronary Angiography

Coronary Arteriosclerosis
University Hospital, Angers
University of Angers, Angers

Unknown

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome (ENEAST)

Isolated Growth Hormone Deficiency | Turner Syndrome | Pediatrics | Social Cognition | Cognitive Functions
Angel Medical Systems

Terminated

IDE-ALERTS Continued Access Study (ALERTS-CAS)

Acute Coronary Syndrome

United States
Angel Medical Systems

Recruiting

AngelMed Guardian® System PMA Post Approval Study

Acute Coronary Syndrome

United States
Alisa Apreleva
ALS Centre Moscow

Unknown

Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS

ALS (Amyotrophic Lateral Sclerosis) | Dysphagia | Aspiration Pneumonia | Dyspnea | Breathlessness | Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Hypernasality | Dysarthria, Flaccid | Dysarthria, Spastic | Dysarthria, Mixed

Russian Federation, United Kingdom
Angelo Auricchio

Terminated

Validation Of A New S-ICD Algorithm To Reduce Oversensing Of Dynamic T-Waves In Patients With Brugada Syndrome (DE-08-16)

Brugada Syndrome 1S

Belgium, Italy, Switzerland
Centre de recherche du Centre hospitalier universitaire...
University Hospital, Angers

Completed

Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19). (APEL-COVID)

Covid19

Canada
Angela N Fellner PhD CCRP

Completed

Modifying Exercise for the COPD Patient

Pain | Arthritis | Chronic Obstructive Pulmonary Disease

United States
Angela Stockton
Northumbria University

Completed

Acute Effect of Pomegranate Extract on Cognitive Function (POM-03)

Mental Processes

United Kingdom
Angelo Biviano

Completed

Multipolar Mapping and Atrial Arrhythmias

Atrial Fibrillation or Atrial Flutter

United States
Angela Moore
Almirall, SAS

Completed

Sarecycline Truncal Acne Safety and Efficacy Response (TASER)

Acne Vulgaris

United States
Clinical Centre of Serbia
University of California, Los Angeles

Unknown

Distal Venous Arterialisation of Ischemic Limb

Critical Limb Ischemia

Serbia
Candela Corporation

Recruiting

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Scars | Acne | Wrinkle | Tattoo Removal | Skin Conditions | Hair Reduction | Benign Cutaneous Vascular Lesions

United States, Israel
Aeglea Biotherapeutics

Terminated

A Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency

Arginase I Deficiency | Hyperargininemia

Canada
Aeglea Biotherapeutics

Completed

A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency (AEB1102)

Arginase I Deficiency | Hyperargininemia

United States, Canada, United Kingdom, Portugal
Aeglea Biotherapeutics

Completed

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Arginase I Deficiency | Hyperargininemia

United States, Italy, Canada, France, United Kingdom, Austria, Germany
Candela Corporation

Active, not recruiting

Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™

Wrinkle | Pigmented Lesions

United States
Candela Corporation

Active, not recruiting

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro™/GentleMax Pro Plus™

Unwanted Fine Facial Hair

United States
Candela Corporation

Completed

Safety & Efficacy Evaluation of a Radiofrequency & Laser/Light System for Improvement of Skin Texture

Skin Texture Irregularities | Facial Skin Wrinkles

United States
Aeglea Biotherapeutics

Completed

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Arginase I Deficiency | Hyperargininemia

United States, Canada, United Kingdom, Portugal
Aeglea Biotherapeutics

Completed

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States, Canada
Aegera Therapeutics

Terminated

AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Leukemia

United States, Canada, Germany
Aegera Therapeutics

Completed

Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy

Chronic Pain | Diabetic Peripheral Neuropathy

United States, Canada, Bulgaria, Romania
Aegera Therapeutics

Completed

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Leukemia, Myelomonocytic, Acute

United States, Canada
Aegera Therapeutics

Terminated

A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer

Carcinoma | Pancreas

United States
Angela DeCandia
College Park Industries

Completed

A Comparative Analysis Between College Park Sidekick Feet and Conventional Stubby Prosthesis

Amputation Stumps

United States
Candela Corporation

Completed

Determination of Safety and Efficacy of a Laser With Cooling for Treatment of Skin

Aged Skin
Candela Corporation

Completed

Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions

Pigmented Lesions | Skin Texture

United States
Candela Corporation

Completed

Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea

Erythematotelangiectatic Rosacea

United States
Aeglea Biotherapeutics

Completed

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

Advanced Cancers

United States
Candela France

Completed

Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae

Striae

France
Aegera Therapeutics

Terminated

A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Candela Corporation

Recruiting

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

Skin Condition | Wrinkle | Skin Laxity

United States, Canada, Spain
Candela Corporation

Recruiting

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

Meibomian Gland Dysfunction | Dry Eye Disease

United States, Argentina
Candela Corporation

Active, not recruiting

A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles

Wrinkle

United States, Israel
Candela Corporation

Active, not recruiting

Functional Usability and Feasibility Testing of the Profound Matrix™ System

Acne Scars - Mixed Atrophic and Hypertrophic | Wrinkle

United States, Israel
Candela Corporation

Completed

PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles

Benign Pigmented Lesions | Facial Wrinkles

United States
Candela Corporation

Completed

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus

Onychomycosis | Acne | Wrinkle | Pigmented Lesions | Pseudofolliculitis Barbae | Unwanted Hair | Vascular Lesion

United States
Aeglea Biotherapeutics

Terminated

A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency

Homocystinuria Due to Cystathionine Beta-Synthase Deficiency

United States, United Kingdom, Australia
Candela Corporation

Completed

The CO2RE® System for Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus

United States
Candela Corporation

Withdrawn

Bipolar RF Microneedling for Improved Laxity and Lift of the Submental and Neck Tissue and Effect on Elastin

Skin Laxity

United States
Syneron Candela

Unknown

UltraShape Power in Combination With U-sculpt-n Transducer

Circumference Reduction

Israel

Clinical Trials Sponsored by Angela Contri

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations